Search

everythinglearnresearchcommunity

for

Search:↓

Two patients treated with TAC for mouth fibrosis improved but developed Cushing's Syndrome symptoms.

A patient experienced permanent hair loss due to an allergic reaction to a corticosteroid injection.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Pentoxifylline alone and combined with triamcinolone acetonide is effective for treating localized alopecia areata, with the combination showing the highest effectiveness.

Injecting triamcinolone into the eyebrow area may help eyelash regrowth in alopecia areata patients.

Combining epinephrine with a steroid may help regrow hair in severe alopecia areata cases.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

Standard intralesional corticosteroids are the best treatment for patchy alopecia areata.

Both steroids effectively promote hair growth for at least 9 months.

Intralesional steroid injections are safe and effective for treating severe alopecia areata.

Triamcinolone can regrow hair in alopecia areata, but the effect is temporary.

Patients treated with long-term intralesional corticosteroids for alopecia areata should be monitored for bone density changes and advised on osteoporosis prevention.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

The patient's hair loss from alopecia totalis returned despite initial successful treatment.

Both microneedling and injections are equally effective for treating alopecia areata.

Injecting steroids like Triamcinolone Acetonide for skin treatments can cause Cushing's Syndrome.

Ultraviolet light helped hair growth more effectively than triamcinolone acetonide.

Alopecia areata mainly affects young people and has significant psychological impacts, especially in males.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

New treatments for Dissecting cellulitis show promise, but more research is needed to understand the disease and establish a standard treatment plan.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

Platelet-rich plasma (PRP) injections successfully treated a woman's steroid-resistant hair loss, causing hair to regrow within a month.

Stopping sunscreen use on the forehead led to hair regrowth in a woman with frontal fibrosing alopecia.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Hair transplants can lead to hair loss from lichen planopilaris, and patients should be tested and wait two years before the procedure.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Hair transplant for eyebrow alopecia areata provided significant relief and improved treatment response.